| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Amlitelimab | KY-1005; SAR-445229 | Phase 3 Clinical | Kymab Ltd, Sanofi | Alopecia Areata; Asthma; Celiac Disease; Dermatitis, Atopic; Eczema; Hidradenitis; Immune System Diseases; Lung Diseases, Interstitial; Scleroderma, Systemic | 詳細 |
| APG-279 | APG279; APG-990/APG777 | Phase 2 Clinical | Apogee Therapeutics Inc | Dermatitis, Atopic | 詳細 |
| IMB-101 (IMBiologics) | IMB-101 (IMBiologics); HDM-3019; IMB101 (IMBiologics); HDM3019; NAV-240 | Phase 2 Clinical | IMBiologics Corp | Arthritis, Rheumatoid; Hidradenitis Suppurativa | 詳細 |
| IBI356 | IBI-356; IBI356 | Phase 2 Clinical | Autoimmune Diseases; Dermatitis, Atopic | 詳細 | |
| RP-3 | RP-3 | Phase 2 Clinical | Replimune Inc | Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| HS-130 | HS-130 | Phase 1 Clinical | Heat Biologics | Solid tumours | 詳細 |
| mRNA-2752 | mRNA-2752 | Phase 1 Clinical | Astrazeneca Plc, Moderna Inc | Lymphoma; Neoplasms; Solid tumours | 詳細 |
| MQ-710 | MQ-710 | Phase 1 Clinical | Imvaq Therapeutics Corp, Memorial Sloan Kettering Cancer Center | Adenocarcinoma, Sebaceous; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Hemangiosarcoma; Melanoma; Neoplasm Metastasis; Neoplasms; Paget Disease, Extramammary; Sarcoma, Kaposi; Solid tumours; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| OX-118 | OX-118 | Phase 1 Clinical | Oxion Biologics AB | Autoimmune Diseases; Immune System Diseases; Rheumatic Diseases | 詳細 |
| M-5542 | M5542; M-5542 | Phase 1 Clinical | Merck & Co Inc | 詳細 | |
| ABCL-575 | ABCL-575; ABCL575 | Phase 1 Clinical | AbCellera Biologics Inc | Dermatitis, Atopic | 詳細 |
| APG-990 | APG-990; APG990; PR-007; PR007 | Phase 1 Clinical | Paragon Therapeutics Inc | Dermatitis, Atopic | 詳細 |
| SAR-443726 | SAR-443726 | Phase 1 Clinical | Sanofi | Dermatitis, Atopic | 詳細 |